Výsledky vyhledávání - "Edgar H. Adams"

Adverse reactions to over-the-counter cough and cold products among children: the cases managed out of hospitals

Autor: Steven M. Marcus, Edgar H. Adams, Alvin F. Chu, Bruice Ruck, Zdravko P. Vassilev

Publikováno v: Journal of Clinical Pharmacy and Therapeutics. 34:313-318

Prompted by continuing concerns about the safety of over-the-counter (OTC) cough and cold medications, we examined the frequency and severity of pediatric adverse drug reactions (ADRs) to OTC cough and cold products reported to a major poison control

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0ba766aad9d1513e1c3c8b3c5a7589b
https://doi.org/10.1111/j.1365-2710.2008.01010.x

Zobrazit plný text záznamu

Evaluation of adverse drug reactions reported to a poison control center between 2000 and 2007

Autor: Zdravko P. Vassilev, Edgar H. Adams, Alvin F. Chu, Bruce Ruck, Steven M. Marcus

Publikováno v: American Journal of Health-System Pharmacy. 66:481-487

Purpose. The likelihood of hospitalization caused by adverse drug reactions (ADRs) from commonly implicated therapeutic groups is discussed. Methods. A retrospective analysis of the computerized records of exposure cases involving pharmaceutical subs

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44155827425050591b117133c336707b
https://doi.org/10.2146/ajhp080267

Zobrazit plný text záznamu

A Study of AVINZA�(Morphine Sulfate Extended-Release Capsules) for Chronic Moderate-to-Severe Noncancer Pain Conducted Under Real-World Treatment Conditions?The ACCPT Study

Autor: Richard Ghalie, Edgar H. Adams, Yvonne Ace-Wagoner, Paul Chwiecko, George C Perdikis, Bethany Mangefrida, Frank A Kunkel, Mark E Duerden

Publikováno v: Pain Practice. 6:254-264

This study evaluated the clinical effects and pattern of use of AVINZA((r)), morphine sulfate extended-release tablets, under real-world treatment conditions. Opioid-naive subjects or subjects who have failed other opioids were eligible if they had c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::053f4ade3273dca0c16fe33dc6dfb626
https://doi.org/10.1111/j.1533-2500.2006.00094.x

Zobrazit plný text záznamu

The Diversion of Ultram®, Ultracet®, and Generic Tramadol HCl

Autor: James A. Inciardi, Anne Geller, Edgar H. Adams, Edward C. Senay, Alvaro Muñoz, George E. Woody, Theodore J. Cicero

Publikováno v: Journal of Addictive Diseases. 25:53-58

Ultram (tramadol HCL) was approved by the Food and Drug Administration in 1994 as a non-scheduled drug under the Controlled Substance Act. The non-scheduled status was contingent on the development and implementation of a comprehensive post-marketing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7692cf8970f6845d0a67e301af6ff6f
https://doi.org/10.1300/j069v25n02_08

Zobrazit plný text záznamu

A Comparison of the Abuse Liability of Tramadol, NSAIDs, and Hydrocodone in Patients with Chronic Pain

Autor: Sidney H. Schnoll, Edgar H. Adams, Scott Breiner, James A. Inciardi, Theodore J. Cicero, Anne Geller, George E. Woody, Edward C. Senay

Publikováno v: Journal of Pain and Symptom Management. 31:465-476

Concern about abuse/dependence in chronic pain patients taking opioid analgesics may lead to undertreatment of pain, yet little is known about the prevalence of abuse/dependence in these patients and how it differs among analgesic agents. The objecti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e7b9ba90680d92a42dc56e28ce75bea
https://doi.org/10.1016/j.jpainsymman.2005.10.006

Zobrazit plný text záznamu

An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride)

Autor: James A. Inciardi, Alvaro Muñoz, Edward C. Senay, Sidney H. Schnoll, Theodore J. Cicero, Edgar H. Adams, Anne Geller, George E. Woody

Publikováno v: Drug and Alcohol Dependence. 72:163-168

Objective: Assess the validity of medical products reporting program (MEDWatch) reports of abuse/dependence and withdrawal associated with Ultram (tramadol). Methods: Reports of possible abuse/dependence or withdrawal associated with Ultram during 13

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::410d72c4cb02b173410bb659e0e658f8
https://doi.org/10.1016/s0376-8716(03)00198-4

Zobrazit plný text záznamu

A postmarketing surveillance program to monitor Ultram® (tramadol hydrochloride) abuse in the United States

Autor: James A. Inciardi, Theodore J. Cicero, Sidney H. Schnoll, George E. Woody, Alvaro Muñoz, Edgar H. Adams, Anne Geller, Edward C. Senay

Publikováno v: Drug and Alcohol Dependence. 57:7-22

Tramadol HCl, marketed as Ultram in the USA, was introduced as a non-scheduled drug in April 1995 based on the assumption that the risk of abuse was sufficiently low to warrant a non-scheduled status. However, approval was contingent upon the develop

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33b4027f925be93173eb1ad14e36d6ee
https://doi.org/10.1016/s0376-8716(99)00041-1

Zobrazit plný text záznamu

Risk of Cocaine Use and Dependence

Autor: Joseph Gfroerer, Edgar H. Adams

Publikováno v: Substance Use & Misuse. 32:1781-1786

Data were obtained from the preliminary files (N = 8,038) of the 1985 National Household Survey on Drug Abuse (NHSDA). The analysis was restricted to 435 adults between the ages of 18 and 54 who had used cocaine in the past year. The questions in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3b064cb58e8a14074a56c9f4ee8ea134
https://doi.org/10.3109/10826089709035581

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání